title: Effects of U0126 and MK2206 on cell growth and re-growth of endometriotic stromal cells grown on substrates of varying stiffness.
abstract: Endometriosis is a common gynecological disorder responsible for infertility and pelvic pain. A complete cure for patients with endometriosis awaits new targets and strategies. Here we show that U0126 (a MEK inhibitor) and MK2206 (an AKT inhibitor) synergistically inhibit cell growth of deep endometriotic stromal cells (DES) grown on polyacrylamide gel substrates (PGS) of varying stiffness (2 or 30 kilopascal [kPa]) or plastic in vitro. No significant differences in cell proliferation were observed among DES, endometrial stromal cells of patients with endometriosis (EES) from the proliferative phase (P), EES-S (secretory phase) and EES-M (menstrual phase) compared to cells grown on a substrate of the same stiffness at both higher (U0126 [30 μM] and MK2206 [9 μM]) and lower (U0126 [15 μM] and MK2206 [4.5 μM]) combined doses. However, cell re-growth of DES after drug discontinuation was higher than that of EES-P and EES-S when cells were grown on rigid substrates at both combined doses. Combination U0126 and MK2206 treatment is more effective than each drug alone in cell growth inhibition of DES. However, further studies are required to investigate the mechanisms underlying high cell survival and proliferation after drug discontinuation for developing target therapies that prevent recurrence.
authors.affiliation: CHU Clermont-Ferrand, CHU Estaing, Chirurgie Gynécologique, Clermont-Ferrand, France.|Clermont Université, Université d'Auvergne, ISIT UMR6284, Clermont-Ferrand, France.|CNRS, ISIT UMR6284, Clermont-Ferrand, France.
authors.forename: Sachiko
authors.initials: S
authors.lastname: Matsuzaki
authors.affiliation: CHU Clermont-Ferrand, CHU Estaing, Chirurgie Gynécologique, Clermont-Ferrand, France.
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Pouly
authors.affiliation: CHU Clermont-Ferrand, CHU Estaing, Chirurgie Gynécologique, Clermont-Ferrand, France.|Clermont Université, Université d'Auvergne, ISIT UMR6284, Clermont-Ferrand, France.|CNRS, ISIT UMR6284, Clermont-Ferrand, France.
authors.forename: Michel
authors.initials: M
authors.lastname: Canis
mesh_terms: D000180:Acrylic Resins / Q000737:chemistry*; D000328:Adult; D017209:Apoptosis / Q000187:drug effects; D002070:Butadienes / Q000494:pharmacology*; D049109:Cell Proliferation / Q000187:drug effects*; D002478:Cells, Cultured; D016922:Cellular Senescence / Q000187:drug effects; D004338:Drug Combinations; D004715:Endometriosis / Q000378:metabolism / Q000473:pathology; D004717:Endometrium / Q000166:cytology; D005260:Female; D006244:Hardness; D006575:Heterocyclic Compounds, 3-Ring / Q000494:pharmacology*; D006801:Humans; D009570:Nitriles / Q000494:pharmacology*; D010969:Plastics / Q000737:chemistry*; D017154:Stromal Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D055815:Young Adult
chemical_list: D000180:Acrylic Resins; D002070:Butadienes; D004338:Drug Combinations; D006575:Heterocyclic Compounds, 3-Ring; C548887:MK 2206; D009570:Nitriles; D010969:Plastics; C113580:U 0126; C016680:polyacrylamide gels